Verastem reported $19.58M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US $ 8821M 991M
AstraZeneca AZN:LN 10.51B 1.79B
Curis CRIS:US $ 17.19M 1.49M
Cytokinetics CYTK:US $ 81.7M 4.39M
Epizyme EPZM:US $ 59.62M 3.25M
Gilead Sciences GILD:US $ 6393M 89M
Immunogen IMGN:US $ 60.93M 1.62M
Laboratory Of America LH:US $ 3211.7M 113.9M
Novartis NOVN:VX 9.96B 998M
Pfizer PFE:US $ 15788M 3271M
Tg Therapeutics TGTX:US $ 68.89M 26.38M
Verastem VSTM:US $ 19.58M 2.52M
YTE INCY:US $ 616.69M 135.42M
Ziopharm Oncology ZIOP:US $ 9.08M 1.97M